Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

ConjuChem Inc (CJB.TO)

WAIT
Coming-out with clinical trial results on Monday. Stock has had a huge run in anticipation of this. Good company, but wait for the results.
DON'T BUY
A very interesting company but has had a big run. Would look elsewhere.
SELL
An incredibly expensive stock. Market has been expecting some trial news that they believe will cause drug companies to want to own the Company. Risky.
PAST TOP PICK
(A top pick on Dec 4/03. Up 156%.) Still likes of a lot. Will probably go into the index this month. A couple of analysts are calling it the next RIM. The market for their diabetes product is absolutely gigantic.
HOLD
Has great technology. Had a huge run. They have a phase two trial going on for diabetes and if it works, the stock is $20. If not, could go back to $.50. Caution.
TOP PICK
Product had a wide platform of multiple uses and a couple of products didn't work so stock dropped drastically. Now using it with a diabetes product, which is getting a lot of attention. A trading stock. Trade at $7/8 before the trial results come out
WEAK BUY
New issue gave them needed cash. In the process of digesting it. Now looking for some better results in the diabetes applications. Could be a joint venture down the road. Volatile area.
DON'T BUY
Up 317% on a year to date basis. Seems to be finding support around the $1.60 level. May be a little high now.
Showing 16 to 23 of 23 entries